Answers are grounded in this paper and cite their sources.
Although the incidence of gastric cancer has decreased over the last several decades, it continues to be the second most common cause of cancer death world-wide. While much of the current literature focuses on adjuvant and neo-adjuvant treatment of gastric cancer, there remains a relative paucity of longitudinal studies across low volume non-cancer hospitals. In this retrospective study, we set out to review our institutional data from the last two decades to look for any improvement in the outcomes of gastric cancerpatients and the factors responsible.
No takes yet. Share an insight, caveat, or question.
Sandeep Anantha Sathyanarayana (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: